Comparison of Analgesic Effects of Subcostal Transversus Abdominis Plane Block and Rectus Sheath Block in Robotic-Assisted Laparoscopic Prostatectomies
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Postoperative Pain
- Sponsor
- Diskapi Yildirim Beyazit Education and Research Hospital
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- post operatif analgesia consumption
- Status
- Not Yet Recruiting
- Last Updated
- last year
Overview
Brief Summary
In this research, we aim to compare the postoperative analgesic efficacy of these two peripheral blocks in patients undergoing RALP who have received preoperative TAP block and RSB block.
Detailed Description
"Robotic-assisted laparoscopic prostatectomy (RALP) is a minimally invasive and superior technique that provides better visualization and maneuverability compared to open and laparoscopic surgical techniques. Previous studies have shown that RALP offers better postoperative oncological and physiological outcomes compared to open and laparoscopic techniques. However, RALP patients still experience pain lasting for several days postoperatively, which requires the use of analgesics such as opioids. This pain is associated with port site incisions, dissection of the prostate and surrounding tissues, bladder spasms, and transurethral catheter irritation. For this purpose, previous studies have utilized central and peripheral methods to reduce postoperative pain. Previous studies have demonstrated the analgesic benefits of TAP block and rectus sheath block in robotic-assisted radical prostatectomies. However, the number of studies in this area is limited. In this research, we aim to compare the postoperative analgesic efficacy of these two peripheral blocks in patients undergoing RALP who have received preoperative TAP block and RSB block.
Investigators
Zeynep Koc
principal investigator
Diskapi Yildirim Beyazit Education and Research Hospital
Eligibility Criteria
Inclusion Criteria
- •Patients aged 18-79 who underwent robotic radical prostatectomy
- •Patients have ASA (American Society of Anesthesiologists) physical status score of 1-3.
Exclusion Criteria
- •Patients with an allergy to local anesthetic agents
- •a platelet count below 100,000
- •INR value above 2
Outcomes
Primary Outcomes
post operatif analgesia consumption
Time Frame: postoperative 24 hous
postoperative iv-PCA tramadole dose for the first 24 hours from iv-PCA devices.
Secondary Outcomes
- numerical rating scale (NRS) at rest(postoperative 24. hour)
- NRS during coughing(postoperative24. hour)
- postoperative nosia and vomiting (PONV)(postoperative 24 hours)